RELMADA THERAPEUTICS, INC. (RLMD) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Jun-30-19	Jun-30-18	Jun-30-17	Jun-30-16
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	5.4	44.4	2.5	36.3	9.2	2.2	1.7	8.5
Short-term investments	142.9	167.5	114.6	80.2
Other current assets	4.5	11.4	1.0	0.5	0.8	0.5	0.8	0.8
Total current assets	152.9	223.3	118.1	116.9	10.0	2.7	2.5	9.3
Property, plant, and equipment, net			0.0	0.0	0.0	0.0	0.0	0.5
Other fixed assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4
Total assets	152.9	223.3	118.2	117.1	10.2	3.0	2.8	10.2

Accounts payable	5.3	11.2	8.3	0.5	0.9	0.8	0.5	1.3
Accrued expenses	7.2	3.9	4.3	0.8	1.3	0.7	0.4	0.6
Short-term debt	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.3
Short-term debt				0.1	0.4	0.3	0.3	0.3
Other current liabilities						4.2	0.2	0.9
Total current liabilities	12.5	15.1	12.6	1.5	2.6	5.9	1.4	3.1
Long-term debt						9.9
Other liabilities						-7.2		0.1
Total liabilities	12.5	15.1	12.6	1.5	2.6	8.6	1.4	3.2

Shareholders' equity [+]	140.4	208.3	105.6	115.7	7.6	-5.5	1.5	7.0
Paid-in capital	602.5	513.3	284.9	235.5	119.3	88.8	86.8	86.1
Retained earnings		-305.1	-179.3	-119.9	-111.7	-94.3	-85.4	-79.1
Tangible shareholders' equity	140.4	208.3	105.6	115.7	7.6	-5.5	1.5	7.0